drugset / Trial / NCT02516618
Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects
RandomizedSingle-groupQuadruple-blindBasic science
Summary
The primary objective of the study is to assess the safety and tolerability of a single dose of subcutaneous (SC) or intravenous (IV) administered fasinumab in healthy Japanese subjects.
Timeline
- Start
- 2015-07
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fasinumab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.